Company research / AGTX

Agentix Corp. (AGTX)

CIK 0001603345 · OTC · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

For the year ended 2023-03-31, Agentix Corp. reported revenue of $0. Revenue fell 100.0% from the prior annual period.

Key ratios (year ended 2023-03-31)

-100.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.